Z-1183-2021 Class III Terminated

Recalled by OraSure Technologies, Inc. — Bethlehem, PA

FDA device recall Z-1183-2021 was initiated by OraSure Technologies, Inc. on Feb 5, 2021 and is designated Class III. Reason for recall: Incorrect lot of Substrate Reagent (TMB) may be included in the kit. The original kit box labeling and the specification sheet listed the Substrate Reagent (TMB) lot 6676239, but contained Substrate… The recall status is terminated (terminated Mar 30, 2023). Affected quantity: 16 units.

Recall details

Product Type
Devices
Report Date
Mar 17, 2021
Initiation Date
Feb 5, 2021
Termination Date
Mar 30, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16 units

Product description

Methamphetamine Intercept Microplate kit EIA - IVD qualitative determination of methamphetamine in oral fluid, PN 11041C.

Reason for recall

Incorrect lot of Substrate Reagent (TMB) may be included in the kit. The original kit box labeling and the specification sheet listed the Substrate Reagent (TMB) lot 6676239, but contained Substrate Reagent (TMB) lot 6679623, should not affect performance.

Distribution pattern

US Nationwide distribution in the states of KS, NJ, OH, VA.

Code information

Lot 6681090, Exp date 2021-03. UDI: 608337000191

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1183-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1183-2021. Report a data issue: hello@regdatalab.com.